SEC Form D private-offering filing

Cadrenal Therapeutics, Inc.

Name: Cadrenal Therapeutics, Inc. - new SEC Form D private-offering filing, Ponte Vedra, FL
Published: 2025-12-31

A new SEC Form D private-offering notice from Ponte Vedra, FL, a $4,396,329 filer-stated offering target in Biotech. The source filing is one click away.

Cadrenal Therapeutics, Inc. site↗ Verified via SEC Form D

Late-stage biopharmaceutical company developing therapies for immune and thrombotic disorders, including a 12-LOX inhibitor for heparin-induced thrombocytopenia

Filed 2025-12-31Filed to raise $4,396,329First money in 2025-12-16Raised so far $4,396,329HQ (as filed) Ponte Vedra, FLSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified cadrenal.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Florida →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.